Skip to content
Open access

Humanistic burden of melanoma recurrence after definitive surgical resection: Patient and caregiver perspectives from the United States.

Oct 2026 · JCO Oncology Practice · Vol 22, pp. 424-424 · 0 citations

TL;DR

Based on the feedback, melanoma recurrence, especially distant recurrence, was associated with substantial humanistic burden, including emotional, physical, functional, social, and financial impacts for both patients and caregivers.

Abstract

424 Background: Melanoma after definitive surgical resection has a high risk of recurrence; adding targeted or immunotherapy reduces, but does not eliminate, this risk. This qualitative study aimed to describe the humanistic burden of melanoma recurrence from the patients’ and caregivers’ perspectives in the US, given the limited real-world data. Methods: Semi-structured qualitative interviews were conducted via teleconference with resected stage IIB/C–III cutaneous melanoma patients with recurrence and unpaid caregivers of such patients. Participants were recruited independently (not as dyads). Interviews explored the impact of recurrence on various aspects of their lives. Transcripts were anonymized and analyzed using thematic analysis (NVivo). Results: We interviewed 17 patients with recurrence and 11 caregivers; distant recurrence (DR) was reported by 8 patients and 2 caregivers. Recurrence (especially DR) adversely affected patient quality of life (QOL) across emotional, physical, functional, social, financial, and work domains. Common patient-reported impacts included emotional burden (anxiety, grief, hopelessness, anger), fear of progression/death, impaired daily functioning, social withdrawal, cosmetic concerns, financial burden, and employment impact. Caregivers described parallel emotional and practical burdens, including caregiving strain, anxiety, work disruption, high costs, and effects on their own QOL. Conclusions: Based on the feedback, melanoma recurrence, especially distant recurrence, was associated with substantial humanistic burden, including emotional, physical, functional, social, and financial impacts for both patients and caregivers. These findings highlight the importance of recurrence prevention and the need for novel interventions to further reduce recurrence risk and humanistic burden. Impact of melanoma recurrence on patients: Select key themes and phrases. Theme Phrases Emotional burden “I get very angry for no reason sometimes and nervous.” Fear of disease progression “Is there something inside of me growing? Is this going to kill me? Am I going to see my kid graduate from high school?” Physical symptom burden “In my brain, it (arm) is supposed to be back like it used to be, and it ain’t. I have so much pain.” Impaired daily functioning “That's been a struggle trying to keep up with typical daily living, like doing laundry and cooking meals and washing dishes." Financial burden “Yes, it’s copays, gas, food. When I would leave, I knew automatically it’s $100 every time I go…2-3 times/week.” Employment impact “..we made the decision that it was better for my health to stay part-time.”

Read PDF

Similar papers

Open access Oct 2026

Retrospective Patient Perspectives on Symptom Burden, Emotional Experiences, and Unmet Needs in Nasopharyngeal Carcinoma: A Qualitative Study

The findings support structured diagnostic communication, coordinated management of co-occurring symptoms with accessible out-of-hours support, and transitional follow-up that includes rehabilitation guidance and psychological screening.

Wei-Wei Zuo, Yuan-Yuan Wang, Li Wang et al. · 0 citations
Review Open access Oct 2026

Hope for a cure: Exploratory analysis of prognostic awareness of people living with advanced lung cancer.

402 Background: Despite improved outcomes for stage IV lung cancer over the last decade, it remains the leading cause of cancer-related mortality. Discussions of prognosis and treatment decisions are complex and influenced by multiple factors. This study examines characteristics of patients with advanced lung c...

C. Ducille, U. Roy, K. Glynn et al. · 0 citations
Review Open access Oct 2026

Multifaceted aspects of living with long-term metastatic breast cancer.

362 Background: Metastatic breast cancer (MBC) has many ongoing physical, emotional, and information challenges, making supportive services a critical component of care. While many patients report favorable quality of life (QoL), their reflections on their cancer journey reveal nuanced experiences. Understandin...

A. Davenport, Kayla Willams, C. Hery et al. · 0 citations
Review Open access Oct 2026

A qualitative study to explore the patient experience of living with early breast cancer and perspectives on survivorship.

The findings help identify which aspects of HRQoL are meaningful to patients with eBC and inform conceptual relevance for clinical outcomes assessment (COA) measurement strategies in future clinical trials and other patient-centered research.

R. Sugarman, S. Mannix, N. Ow et al. · 0 citations
Open access Nov 2026

Evaluation of fear of cancer recurrence after treatment in patients with aggressive lymphomas: a cross-sectional study

Fear of cancer recurrence (FCR) is a major psychological concern among cancer survivors, yet data remain limited among survivors of aggressive lymphomas (AgL). This study aimed to assess the prevalence and severity of FCR and to explore demographic and clinical factors associated with clinically significant FCR in...

M. Rebah, M. Sayadi, Wafa Miled et al. · 0 citations
Oct 2026

Wish to Hasten Death in Advanced Cancer Patients Receiving Palliative Care. A Cross-Sectional Study in a Latin American Setting.

BACKGROUND The wish to hasten death (WTHD) is a recognized expression of suffering in advanced illness, yet remains systematically underexplored in Latin America, where data are virtually absent. OBJECTIVES To determine the prevalence of the WTHD, and identify associated factors and predictors in advanced cancer pati...

María Del Pilar Mendiguren, Agustina Iturri, María Del Pilar De Antueno et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.